Oxford to Test Inhale Version of COVID-19 Vaccine With 30 Volunteers
On Thursday the Oxford University said that it was launching a study to investigate the immune response of a nasal administration of its COVID- 19 vaccine developed with AstraZeneca, with 30 healthy volunteers aged 18 to 40 for the initial trial.
Last September British researchers said that inhale version of the COVID-19 vaccine candidate developed by Oxford University and Imperial College will be tested to see if they deliver a localized immune response in the respiratory tract.
